HDL Therapeutics
ApprovedHDL Therapeutics is revolutionizing the way that patients with atherosclerosis not only manage their disease, but treat it.
Founded
2015
Focus
CardiovascularMetabolic
About
HDL Therapeutics is revolutionizing the way that patients with atherosclerosis not only manage their disease, but treat it.
Company Info
TypePrivate
Founded2015
LocationHouston, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile